Essertines-sur-Rolle, Switzerland

Stéphane Gorgerat

This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Bracco Suisse Sa. Active years: 2019.


% Patents Active = 100.0

 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Stéphane Gorgerat: Innovator in Microvesicle Technology

Introduction

Stéphane Gorgerat is a notable inventor based in Essertines-sur-Rolle, Switzerland. He has made significant contributions to the field of microvesicle technology, holding 2 patents that showcase his innovative approach to freeze-dried formulations.

Latest Patents

His latest patents include a freeze-dried formulation for gas-filled microvesicles. This invention features a freeze-dried powder composition comprising a phospholipid and a polyethylene glycol, with the polyethylene glycol having a percentage of folded polymeric chains of 40% or higher. The composition is specifically designed for preparing gas-filled microvesicles, enhancing their stability and usability in various applications.

Career Highlights

Throughout his career, Stéphane has worked with prominent companies such as Bracco Suisse SA and Bracco Research SA. His experience in these organizations has allowed him to refine his expertise in the development of innovative pharmaceutical formulations.

Collaborations

Stéphane has collaborated with notable professionals in his field, including Jean Brochot and Feng Yan. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Stéphane Gorgerat's work in microvesicle technology exemplifies the impact of innovative thinking in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing scientific knowledge and improving medical applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…